Satovsky Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Satovsky Asset Management's GILD Position: Q1 2026 in Review
Satovsky Asset Management increased its Gilead Sciences (GILD) stake by 0.59% in Q1 2026, buying an estimated $2.66K and bringing the position to 3,239 shares worth $451K. The position accounts for 0.08% of the portfolio, ranked #37.
Satovsky Asset Management first reported a position in GILD in Q4 2021 and has held it in 15 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Satovsky Asset Management held 3,239 shares of Gilead Sciences worth $451K as of Q1 2026.
- Satovsky Asset Management bought 19 Gilead Sciences shares in Q1 2026, an estimated $2.66K.
- Gilead Sciences made up 0.08% of Satovsky Asset Management's portfolio in Q1 2026, its #37 holding.
- Satovsky Asset Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 15 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Satovsky Asset Management's 13F filing for Q1 2026, filed 14 May 2026.